Indole Compounds Modulating AhR for Cancer Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for cancer and immune system modulation lack effective compounds that specifically target the aryl hydrocarbon receptor (AhR) for therapeutic benefit.
Innovation Solution
Development of novel indole compounds that modulate AhR activity, including specific structures and their pharmaceutical compositions, for use in treating cancer and immune system stimulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments are used for cancer and immune system modulation, then existing therapeutic options are available, but they lack effective compounds that specifically target the aryl hydrocarbon receptor (AhR)
Solution Approach 1:
The patent applies parameter changes by systematically varying the chemical structure of indole compounds (changing molecular parameters such as substituents at positions 3, 5, 6, and 7 of the indole ring) to optimize AhR binding affinity and selectivity. This allows the development of compounds with enhanced therapeutic effectiveness specifically targeted at AhR, resolving the contradiction between general therapeutic availability and specific receptor targeting.
2Reliability
If novel indole compounds are developed to specifically target AhR, then therapeutic effectiveness for cancer and immune modulation is improved, but the complexity of compound development and characterization increases
Solution Approach 1:
The patent applies segmentation by dividing the complex task of AhR-targeted drug development into manageable sections: (1) designing core indole structures with specific substituent patterns, (2) synthesizing individual compound variants, (3) characterizing AhR binding properties, and (4) evaluating therapeutic effects. This segmented approach reduces the overall complexity while maintaining therapeutic effectiveness.
Solution Approach 2:
The patent systematically varies chemical parameters (substituents at different positions on the indole ring) to create a library of compounds with graded AhR binding affinities. This parameter-based approach allows for methodical optimization without requiring complete redesign of the entire development process, thereby managing complexity while improving therapeutic effectiveness.
Data Source
AI summary
The present disclosure relates to indole compounds and pharmaceutical compositions thereof, and their use in stimulating the immune system of patients in need thereof and in treating cancer.